Navigation Links
Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
Date:8/7/2008

e, resulting in amortization of $0.8 million in the month of June 2008. On June 30, 2008, based upon a Black-Scholes valuation model that included a closing price of Genta's common stock of $0.38 per share, an additional expense of $380 million was recorded to mark the conversion feature liability to market, resulting in a total fair value conversion feature liability expense in June of $720.0 million and an expense of $7.2 million was recorded to mark the warrant liability to market.

Net other expense was $0.2 million for the second quarter of 2008 compared to net other income of $0.3 million for the second quarter of 2007, and net other expense was $0.1 million for the six months ended June 30, 2008 compared to net other income of $0.5 million. The difference resulted from lower investment income, owing to lower investment balances, and accrued interest on the convertible notes. The Company has no exposure to auction rate securities.

At June 30, 2008, Genta had cash, cash equivalents and marketable securities totaling $16.3 million compared with $7.8 million at December 31, 2007. During the first six months of 2008, cash used in operating activities was $14.4 million compared with $16.8 million for the same period in 2007, primarily as a result of the timing of payments in the two respective periods. The Company estimates that its average net cash outflow will be $2.0 to $2.5 million per month for the remainder of 2008.

Conference Call and Webcast

Genta management will host a conference call and live audio webcast to discuss these financial results and corporate activities on Thursday, August 7, 2008, at 8:00 am EDT. Participants can access the live call by dialing (877) 634-8606 (U.S. and Canada) or (706) 679-3140 (International). The access code for the live call is Genta Incorporated. The call will also be webcast live at http://www.genta.com/investorrelation/e
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Genta Announces Second Quarter 2008 Financial Results and Conference Call
2. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
3. Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
4. Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
5. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
6. Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
7. Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board
8. Dr. Elizabeth Brown Joins Argenta TEC
9. Syngenta To Build Major Global Biotech Research Center in Beijing, China
10. Genta Restructures Operations to Focus on Priority Initiatives
11. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 ... presentation, Dr. James L. Sherley, director of the Adult ... attention on an often overlooked and under appreciated unique ... “Asymmetric Self-Renewal by Distributed Stem Cells: Misunderstood in the ... his message to congress participants. He gave the ...
(Date:12/24/2014)... 2014 Nashville Fertility Center announced that ... for the American Society for Reproductive Medicine (ASRM), a ... in reproductive medicine. In his new role as ... executive board and will have a voice in furthering ... actively supported ASRM since 1984 when he joined while ...
(Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... , , , , , ... rapid and highly accurate identification of SNP loci. Our SeeSNP ... is fueled by our capacity , to sequence over 20 ... facility apart include: , , ...
... , , , Agencourt offers a full length ... BACs, cosmids and fosmids. Agencourt , has several features that ... turnaround including: , Long Phred20 read lengths , ... Patented SPRI technology , Oracle-based Galaxy LIMS , ...
... , , , , , ... that uses a single protocol to purify a variety of high , ... and produces high quality templates. The single protocol, ease of ... solution for all template , purification needs. , ...
Cached Biology Technology:SEESNP DISCOVERY 2FULL LENGTH INSERT SEQUENCING 2COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION 2COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION 3
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... than 35,000 people and a survey across the entire ... the National Institutes of Health (NIH) has found evidence ... also play a minor role in human height. The ... of the journal Nature Genetics. The variants most ...
... --- Many researchers have tried to create a mathematical model ... models have many different complicated factors, and no model is ... functional equation -- using only two parameters -- to show ... better known as the fruit fly. They hope that the ...
... filed with the Federal Register today a proposed rule ... fishermen and gourmets alike, as endangered under the Endangered ... Service considered the report of a scientific review team ... The scientific review team reported major ...
Cached Biology News:Researchers uncover new piece to the puzzle of human height 2Researchers uncover new piece to the puzzle of human height 3Researchers uncover new piece to the puzzle of human height 4Researchers create mathematical model of fruit fly eyes 2
... The ProteoSpin CBED Micro Kit provides ... buffer exchange and desalting of protein samples. ... using Norgens patented protein resin as an ... KCl, CaCl2,LiCl, CsCl have poor affinities for ...
... 435 is an affordable, compact benchtop ... slides, providing a broad array of ... acquires high-resolution images with high-performance laser ... excitation and emission filter changers, and ...
... CBED Maxi Kit provides a fast and ... protein solutions for buffer exchange, and for removing ... kit is based on spin-column chromatography using Norgens ... such as MgCl 2 , NaCl, KCl, CaCl ...
... Microarray hybridization chamber assembly (1 each) ... Microarray chamber user guide plastic tweezersChambers ... be cleaned and reused. The chamber is ... Microarray kits and all custom oligo microarrays, ...
Biology Products: